AIM: To compare disease severity and clinical outcome of Clostridium difficile infection (CDI) due to PCR-ribotype (RT) 244 with CDI due to other strains present in Auckland. METHOD: A retrospective, case-control study was conducted. Ten cases with CDI due to RT 244 were compared with 20 controls infected with other C. difficile strains. RT 244 isolates were further analysed for antimicrobial susceptibility, binary toxin genes and mutations in the tcdC gene. RESULTS: Cases were significantly more likely to have severe disease than controls (OR 9.33; p=0.015). 50% of cases had community-associated CDI compared with 15% of controls (p=0.078). All RT 244 isolates produced binary toxin and had a single-base pair deletion in tcdC at position 117. CONCLUSION: C. difficile RT 244 is a newly recognised strain in New Zealand. It shares several features that characterise RT 027. Given its propensity to cause severe community-associated disease, a heightened awareness of this strain is needed to ensure early testing in patients admitted from the community with identified risk factors for CDI.
AIM: To compare disease severity and clinical outcome of Clostridium difficile infection (CDI) due to PCR-ribotype (RT) 244 with CDI due to other strains present in Auckland. METHOD: A retrospective, case-control study was conducted. Ten cases with CDI due to RT 244 were compared with 20 controls infected with other C. difficile strains. RT 244 isolates were further analysed for antimicrobial susceptibility, binary toxin genes and mutations in the tcdC gene. RESULTS: Cases were significantly more likely to have severe disease than controls (OR 9.33; p=0.015). 50% of cases had community-associated CDI compared with 15% of controls (p=0.078). All RT 244 isolates produced binary toxin and had a single-base pair deletion in tcdC at position 117. CONCLUSION:C. difficile RT 244 is a newly recognised strain in New Zealand. It shares several features that characterise RT 027. Given its propensity to cause severe community-associated disease, a heightened awareness of this strain is needed to ensure early testing in patients admitted from the community with identified risk factors for CDI.
Authors: Daniel R Knight; Briony Elliott; Barbara J Chang; Timothy T Perkins; Thomas V Riley Journal: Clin Microbiol Rev Date: 2015-07 Impact factor: 26.132
Authors: Stacey Hong; Papanin Putsathit; Narelle George; Christine Hemphill; Peter G Huntington; Tony M Korman; Despina Kotsanas; Monica Lahra; Rodney McDougall; Casey V Moore; Graeme R Nimmo; Louise Prendergast; Jennifer Robson; Lynette Waring; Michael C Wehrhahn; Gerhard F Weldhagen; Richard M Wilson; Thomas V Riley; Daniel R Knight Journal: J Clin Microbiol Date: 2020-10-21 Impact factor: 5.948
Authors: D N Gerding; D W Hecht; T Louie; C E Nord; G H Talbot; O A Cornely; M Buitrago; E Best; S Sambol; J R Osmolski; H Kracker; H H Locher; P Charef; M Wilcox Journal: J Antimicrob Chemother Date: 2015-10-03 Impact factor: 5.790
Authors: N F Foster; D A Collins; S L Ditchburn; C N Duncan; J W van Schalkwyk; C L Golledge; A B R Keed; T V Riley Journal: New Microbes New Infect Date: 2014-04-01
Authors: Agatha N Jassem; Natalie Prystajecky; Fawziah Marra; Pamela Kibsey; Kennard Tan; Patricia Umlandt; Loretta Janz; Sylvie Champagne; Bruce Gamage; George R Golding; Michael R Mulvey; Bonnie Henry; Linda M N Hoang Journal: Can J Infect Dis Med Microbiol Date: 2016-03-29 Impact factor: 2.471